首页 > 市场调查报告书 > 医疗设备

药物递输设备

市场调查报告书

商品编码

1578288

全球自动注射器市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Autoinjectors Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球自动注射器市场需求预计将从 2023 年的 17.8 亿美元达到 2032 年近 71.6 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 16.74%。

自动注射器是一种医疗设备，可以在较少焦虑和压力的情况下自行注射特定药物。使用通常是一次性的弹簧加载注射器很容易。它可用于肌肉内和皮下注射，通常注射到臀部或大腿。它有不同的形状和尺寸以及多种功能，例如可调节注射深度、药物检查视窗、可伸缩针头、自动语音指令和颜色编码的用过指示器。该装置经常被军事人员用于急救，以保护自己免受化学战剂的侵害。

市场动态

全球人口自我给药治疗的广泛增加将成为该市场成长的关键驱动力。减少就诊次数和健康保险机构费用的目标将进一步推动自动注射器市场在慢性病患者中的发展。这个市场的主要吸引力部分是使用注射自我给药治疗类风湿性关节炎、多发性硬化症和糖尿病患者的日益增长的趋势。自动注射器的各种优点可以为製药和生物製药行业节省大量时间和金钱。该市场面临的挑战与用于製造自动注射器中使用的弹簧和其他精密金属部件的材料有关

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球自动注射器市场的每个细分市场进行了包容性评估。自动注射器产业的成长和趋势为本研究提供了整体方法。

市场区隔

自动注射器市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按类型

一次性的
可重复使用的

依技术

手持式
穿戴式

依给药途径

皮下
肌肉注射

按指示

多发性硬化症
类风湿关节炎
糖尿病
过敏反应
其他（肿瘤学、免疫学等）

按最终用户

家庭护理设置
医院和诊所

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲自动注射器市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。自动注射器市场的主要参与者包括 Ypsomed Holding AG、诺华 AG、BD、Medmix Healthcare、礼来公司、赛诺菲、Mylan NV、Amgen Inc.、SHL Medical AG、Recipharm AB。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

简介 - 市场动态
市场驱动因素
市场限制
机会
产业动态
波特五力分析
市场吸引力分析
- 按类型分類的市场吸引力分析
- 按技术分類的市场吸引力分析
- 按给药途径进行的市场吸引力分析
- 按指标进行的市场吸引力分析
- 最终用户的市场吸引力分析
- 市场吸引力分析：按地区

第 4 章：价值链分析

价值链分析
原料分析
- 原料清单
- 原料厂商清单
- 主要原物料价格走势
潜在买家名单
行销管道
- 直效行销
- 间接行销
- 行销通路发展趋势

第 5 章：全球自动注射器市场分析：按类型

按类型概述
按类型分析历史和预测数据
一次性的
可重复使用的

第 6 章：全球自动注射器市场分析：按技术分类

依技术概述
按技术进行历史和预测数据分析
手持式
穿戴式

第 7 章：全球自动注射器市场分析：按管理途径

依给药途径概述
按给药途径进行历史和预测资料分析
皮下
肌肉注射

第 8 章：全球自动注射器市场分析：按迹象分类

按指示概述
按指示进行历史和预测资料分析
多发性硬化症
类风湿关节炎
糖尿病
过敏反应
其他（肿瘤学、免疫学等）

第 9 章：全球自动注射器市场分析：依最终使用者分类

最终用户概述
最终用户的历史和预测数据分析
家庭护理设置
医院和诊所

第 10 章：全球自动注射器市场分析：依地理位置

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 11 章：自动注射器公司的竞争格局

自动注射器市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 12 章：公司简介

顶级公司市占率分析
市场集中度
Ypsomed Holding AG

公司概况
公司收入
产品
最新动态

Novartis AG

公司概况
公司收入
产品
最新动态

公司概况
公司收入
产品
最新动态

Medmix Healthcare

公司概况
公司收入
产品
最新动态

Eli Lilly And Company

公司概况
公司收入
产品
最新动态

Sanofi

公司概况
公司收入
产品
最新动态

Mylan NV

公司概况
公司收入
产品
最新动态

Amgen Inc.

公司概况
公司收入
产品
最新动态

SHL Medical AG

公司概况
公司收入
产品
最新动态

Recipharm AB

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11213513

The global demand for Autoinjectors Market is presumed to reach the market size of nearly USD 7.16 Billion by 2032 from USD 1.78 Billion in 2023 with a CAGR of 16.74% under the study period 2024-2032.

An autoinjector is a medical device that enables the self-administration of a particular drug with less anxiety and stress. It is easy to use a spring-loaded syringe that is generally disposable. It can be used for intramuscular and subcutaneous injection, typically administered into the buttocks or the thigh. It comes in different shapes and sizes along with several features like adjustable injection depth, a drug inspection window, retractable needle, automated voice instruction, and color-coded spent indicator. This device is often used by military personnel for first aid to protect themselves from chemical warfare agents.

MARKET DYNAMICS

The widespread increase in self-administration of drug therapies among the global population will be the key driving force behind this market's growth. The aim to reduce the number of hospital visits and the expenses involved by health insurance agencies will further propel the autoinjectors' market among chronic patients. This market's main attractive segment is the growing trend to treat rheumatoid arthritis, multiple sclerosis, and diabetic patients using injectable self-administration. The various advantages of an autoinjector can save considerable time and money for the pharmaceutical and biopharmaceutical industries. The challenges faced by this market are related to the materials used for the manufacture of springs and other precision metal components used in an autoinjector

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Autoinjectors. The growth and trends of Autoinjectors industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Autoinjectors market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Disposable
Reusable

By Technology

Handheld
Wearable

By Route of Administration

Subcutaneous
Intramuscular

By Indication

Multiple Sclerosis
Rheumatoid Arthritis
Diabetes
Anaphylaxis
Others (Oncology, Immunology etc.)

By End-user

Homecare Settings
Hospitals & Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Autoinjectors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autoinjectors market include Ypsomed Holding AG, Novartis AG, BD, Medmix Healthcare, Eli Lilly And Company, Sanofi, Mylan N.V., Amgen Inc., SHL Medical AG, Recipharm AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. AUTOINJECTORS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Route of Administration
- 3.7.4 Market Attractiveness Analysis By Indication
- 3.7.5 Market Attractiveness Analysis By End-user
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. Disposable Historic and Forecast Sales By Regions
5.4. Reusable Historic and Forecast Sales By Regions

6. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data Analysis By Technology
6.3. Handheld Historic and Forecast Sales By Regions
6.4. Wearable Historic and Forecast Sales By Regions

7. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

7.1. Overview By Route of Administration
7.2. Historical and Forecast Data Analysis By Route of Administration
7.3. Subcutaneous Historic and Forecast Sales By Regions
7.4. Intramuscular Historic and Forecast Sales By Regions

8. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY INDICATION

8.1. Overview By Indication
8.2. Historical and Forecast Data Analysis By Indication
8.3. Multiple Sclerosis Historic and Forecast Sales By Regions
8.4. Rheumatoid Arthritis Historic and Forecast Sales By Regions
8.5. Diabetes Historic and Forecast Sales By Regions
8.6. Anaphylaxis Historic and Forecast Sales By Regions
8.7. Others (Oncology, Immunology etc.) Historic and Forecast Sales By Regions

9. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY END-USER

9.1. Overview By End-user
9.2. Historical and Forecast Data Analysis By End-user
9.3. Homecare Settings Historic and Forecast Sales By Regions
9.4. Hospitals & Clinics Historic and Forecast Sales By Regions

10. GLOBAL AUTOINJECTORS MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE AUTOINJECTORS COMPANIES

11.1. Autoinjectors Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF AUTOINJECTORS INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Ypsomed Holding AG
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. Novartis AG
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. BD
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. Medmix Healthcare
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. Eli Lilly And Company
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. Sanofi
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Mylan N.V.
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. Amgen Inc.
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. SHL Medical AG
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. Recipharm AB
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments